Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetically Engineered Mouse Models of Prostate Cancer in the Postgenomic Era
Juan Martín Arriaga, Cory Abate‐Shen
Cold Spring Harbor Perspectives in Medicine (2018) Vol. 9, Iss. 2, pp. a030528-a030528
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer
Juening Kang, Federico La Manna, Francesco Bonollo, et al.
Cancer Letters (2022) Vol. 530, pp. 156-169
Open Access | Times Cited: 97
A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance
Juan Martín Arriaga, Sukanya Panja, Mohammed Alshalalfa, et al.
Nature Cancer (2020) Vol. 1, Iss. 11, pp. 1082-1096
Open Access | Times Cited: 74
Harnessing the predictive power of preclinical models for oncology drug development
Alexander Honkala, Sanjay V. Malhotra, Shivaani Kummar, et al.
Nature Reviews Drug Discovery (2021) Vol. 21, Iss. 2, pp. 99-114
Closed Access | Times Cited: 66
The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1
Rodrigo Romero, Tinyi Chu, Tania J González-Robles, et al.
Nature Cancer (2024) Vol. 5, Iss. 11, pp. 1641-1659
Open Access | Times Cited: 12
Loss of ARID1A accelerates prostate tumourigenesis with a proliferative collagen-poor phenotype through co-operation with AP1 subunit cFos
Andrew Hartley, Laura C.A. Galbraith, Robin Shaw, et al.
British Journal of Cancer (2025)
Open Access | Times Cited: 1
Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models
Gail P. Risbridger, Roxanne Toivanen, Renea A. Taylor
Cold Spring Harbor Perspectives in Medicine (2018) Vol. 8, Iss. 8, pp. a030536-a030536
Open Access | Times Cited: 69
The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer
Daniel J. Turnham, Nicholas Bullock, Manisha S. Dass, et al.
Cells (2020) Vol. 9, Iss. 11, pp. 2342-2342
Open Access | Times Cited: 60
Emerging experimental models for assessing perineural invasion in human cancers
Shu‐Heng Jiang, Shan Zhang, Hao Wang, et al.
Cancer Letters (2022) Vol. 535, pp. 215610-215610
Closed Access | Times Cited: 37
Regulation and role of CAMKK2 in prostate cancer
Thomas L. Pulliam, Pavithr Goli, Dominik Awad, et al.
Nature Reviews Urology (2022) Vol. 19, Iss. 6, pp. 367-380
Closed Access | Times Cited: 29
Emerging Trends of Nanomedicines in the Management of Prostate Cancer: Perspectives and Potential Applications
Rohitas Deshmukh, Vaibhav Singh, Ranjit K. Harwansh, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 297-297
Open Access | Times Cited: 8
Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis
Josef Leibold, Marcus Ruscetti, Zhen Cao, et al.
Cancer Discovery (2020) Vol. 10, Iss. 7, pp. 1038-1057
Open Access | Times Cited: 49
OncoLoop: A Network-Based Precision Cancer Medicine Framework
Alessandro Vasciaveo, Juan Martín Arriaga, Francisca Nunes de Almeida, et al.
Cancer Discovery (2022) Vol. 13, Iss. 2, pp. 386-409
Open Access | Times Cited: 24
In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis
Juan Martín Arriaga, Kacey Ronaldson-Bouchard, Florencia Picech, et al.
Oncogene (2024) Vol. 43, Iss. 17, pp. 1303-1315
Open Access | Times Cited: 5
Circadian disruption: from mouse models to molecular mechanisms and cancer therapeutic targets
Yu Wang, Hai-dong Guo, Feng He
Cancer and Metastasis Reviews (2022) Vol. 42, Iss. 1, pp. 297-322
Closed Access | Times Cited: 20
TGFβ1 and RGD Cooperatively Regulate SMAD2/3-Mediated Oncogenic Effects in Prostate Cancer Cells in Bio-Orthogonally Constructed Hydrogels
Mugdha Pol, Hanyuan Gao, Joseph M. Fox, et al.
ACS Biomaterials Science & Engineering (2025)
Closed Access
Knowing what’s growing: Why ductal and intraductal prostate cancer matter
Mitchell G. Lawrence, Laura H. Porter, David Clouston, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 533
Closed Access | Times Cited: 31
Modeling metastasis in mice: a closer look
Arianna Giacobbe, Cory Abate‐Shen
Trends in cancer (2021) Vol. 7, Iss. 10, pp. 916-929
Open Access | Times Cited: 24
Diverse Landscape of Genetically Engineered Mouse Models: Genomic and Molecular Insights into Prostate Cancer
Jyoti Kaushal, Simran Takkar, Surinder K. Batra, et al.
Cancer Letters (2024) Vol. 593, pp. 216954-216954
Closed Access | Times Cited: 3
Clonal Lineage Tracing with Somatic Delivery of Recordable Barcodes Reveals Migration Histories of Metastatic Prostate Cancer
Ryan N. Serio, Armin Scheben, Billy Lu, et al.
Cancer Discovery (2024) Vol. 14, Iss. 10, pp. 1990-2009
Closed Access | Times Cited: 3
Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities
Neus Martínez‐Bosch, Alejo Rodríguez‐Vida, Núria Juanpere, et al.
Nature Reviews Urology (2019) Vol. 16, Iss. 7, pp. 433-445
Open Access | Times Cited: 29
Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer
Ivana Heřmanová, Patricia Zúñiga-García, Alfredo Caro‐Maldonado, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 6
Open Access | Times Cited: 27
Nano therapeutic approaches to combat progression of metastatic prostate cancer
Abhimanyu Thakur
Advances in Cancer Biology - Metastasis (2021) Vol. 2, pp. 100009-100009
Open Access | Times Cited: 21
Aberrant androgen action in prostatic progenitor cells induces oncogenesis and tumor development through IGF1 and Wnt axes
Won Kyung Kim, Adam W. Olson, Jiaqi Mi, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 16
The future of patient-derived xenografts in prostate cancer research
Mitchell G. Lawrence, Renea A. Taylor, Georgia B. Cuffe, et al.
Nature Reviews Urology (2023) Vol. 20, Iss. 6, pp. 371-384
Open Access | Times Cited: 8
ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21
Irene Cosi, Annamaria Pellecchia, Emanuele De Lorenzo, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top